E. Ohman J:or Asset Management AB
Position in BMY — Bristol Myers Squibb Co
CIK 2009396
STOCKHOLM, V7
Position in BMY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$4,011,043
-$210,924 QoQ
Shares Held
69,612
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#608
of 2,506 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $142,928,858 across 9 Drug Manufacturers - General names. BMY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,270 | $78,286,802 | |
| 2 | ABBV |
AbbVie Inc.
|
62,362 | $15,692,773 | |
| 3 | JNJ |
Johnson & Johnson
|
59,384 | $15,081,754 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,897 | $11,294,764 | |
| 5 | AMGN |
Amgen Inc
|
19,515 | $7,066,771 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
44,792 | $5,659,021 | |
| 7 | PFE |
Pfizer Inc
|
199,117 | $4,794,737 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
69,612 | $4,011,043 |
All Filings in BMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,011,043 | 69,612 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $4,221,967 | 69,612 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,835,781 | 71,112 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,132,551 | 25,112 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,227,240 | 26,512 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,616,966 | 26,512 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,696,800 | 30,000 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,552,200 | 30,000 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,461,856 | 35,200 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,908,896 | 35,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,806,112 | 35,200 | Shares | Sole | 2024-02-15 | |
| 2023-03-31 | $6,639,898 | 95,800 | Shares | Sole | 2024-04-05 | |
| 2022-12-31 | $6,583,425 | 91,500 | Shares | Sole | 2024-04-05 | |
| 2022-09-30 | $6,590,043 | 92,700 | Shares | Sole | 2024-04-05 | |
| 2022-06-30 | $7,453,600 | 96,800 | Shares | Sole | 2024-04-05 | |
| 2022-03-31 | $7,354,121 | 100,700 | Shares | Sole | 2024-04-05 | |
| 2021-12-31 | $6,864,735 | 110,100 | Shares | Sole | 2024-04-05 | |
| 2021-09-30 | $5,881,498 | 99,400 | Shares | Sole | 2024-04-05 | |
| 2021-06-30 | $6,508,268 | 97,400 | Shares | Sole | 2024-04-05 | |
| 2021-03-31 | $5,612,257 | 88,900 | Shares | Sole | 2024-04-05 | |
| 2020-12-31 | $2,847,177 | 45,900 | Shares | Sole | 2024-04-05 | |
| 2020-09-30 | $2,984,355 | 49,500 | Shares | Sole | 2024-04-05 | |
| 2020-06-30 | $5,021,520 | 85,400 | Shares | Sole | 2024-04-05 | |
| 2020-03-31 | $4,676,586 | 83,900 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||